Back to today’s briefing

Story perspectives

Ellison's £118M Boost for AI Vaccine Research in Oxford

9/1/2025

38 8

Summary

Story summary

Larry Ellison's research group will invest £118 million in AI vaccine research with Oxford University, targeting bacterial infections and antibiotic resistance.
The project, led by Professor Sir Andrew Pollard, seeks to improve understanding of immunity through human challenge models.
Pollard raised concerns about misinformation affecting vaccine effectiveness in the US and its implications for children's health.

1 of 1

Story summary

Larry Ellison's research group will invest £118 million in AI vaccine research with Oxford University, targeting bacterial infections and antibiotic resistance.
The project, led by Professor Sir Andrew Pollard, seeks to improve understanding of immunity through human challenge models.
Pollard raised concerns about misinformation affecting vaccine effectiveness in the US and its implications for children's health.